Why Pharma’s Biggest Marketing Challenge Isn’t a Campaign Problem — It’s a Content Problem

The patient journey has fundamentally changed. With the arrival of AI platforms that integrate electronic medical records, wearable data, and insurance coverage into a single conversational interface, patients are no longer searching for health information — they are prompting, synthesizing, and advocating. Our latest DHC Group Point of View, From Search to Answers: Navigating the Rise of the AI-Informed Patient, tackles the practical implications head-on with exclusive new HCP research powered by Sermo and perspectives from Fullspan Health, Ostro, Perform Media, and HealthCentral.

The Empowered — and Overwhelmed — Patient

DHCG’s latest physician survey tells a complicated story: 55% of HCPs describe consumer AI outputs as “mixed” in clinical accuracy, and over one-third report that AI-generated patient information decreases visit efficiency. Physicians aren’t rejecting AI — 89% want clinically validated tools — but they are absorbing a growing burden of real-time fact-checking that pharma brands have a direct opportunity to address.

The Marketer’s Mandate Has Changed

Visibility is no longer determined by keywords or paid media. In an AI-first ecosystem, discoverability follows authority. Brands must now ensure their clinical content is structured, machine-readable, and evidence-grounded — or risk being hallucinated out of the conversation entirely.

What You’ll Learn

• Why your brand website strategy, measurement framework, and content architecture all need to be rebuilt for AI retrieval
• How to shift from self-promotion to clinical stewardship — and why compliance is now a competitive advantage
• Where physicians say pharma can add the most value in AI-driven tools, and what that means for your next campaign